A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma

Ann Oncol. 1997 May;8(5):500-2. doi: 10.1023/a:1008249328792.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II

MeSH terms

  • Adult
  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Female
  • Folic Acid Antagonists / therapeutic use*
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Quinazolines / therapeutic use*
  • Thiophenes / therapeutic use*

Substances

  • Antimetabolites, Antineoplastic
  • Folic Acid Antagonists
  • Quinazolines
  • Thiophenes
  • raltitrexed